Tagpermanent contraception

Essure contraceptive device: Hazard Alert from TGA

E

Therapeutic Goods Administration, August 30, 2017
Consumers and health professionals are advised that Australasian Medical and Science Ltd (AMSL), in consultation with the TGA, has issued a hazard alert for Essure. AMSL is also recallingunused stock and withdrawing the device from the Australian market.

Read more of Essure contraceptive device: Hazard Alert

The battle over Essure

T

The Washington Post, Published on July 26, 2017 Nobody can say exactly how many women have had Essure implanted since the device went on the market in 2002. Bayer, which is headquartered in Germany, says that more than 750,000 devices have been sold worldwide and that sales “continue to grow.”  In recent years, the [US] Food and Drug Administration has received more than 16,000 adverse-event...

Life Matters Women’s Health Series – Part 3 – Contraception

L

ABC Radio National, Thursday 5 June 2014 9:24AM Guests Alison Bean-Hodges Manager, Gynaecology Assessment Clinic & Sexual Health Service, Women’s Health Nurse Practitioner, The Women’s Professor Jayne Lucke Director of the Australian Research Centre in Sex, Health & Society at La Trobe University. Honorary Professor at The University of Queensland and a member of the Steering Committee of...

Your sidebar area is currently empty. Hurry up and add some widgets.